肾细胞癌胰腺转移灶在长轴视野PET/CT上对[18F]SiTATE的摄取
本文报告一例61岁女性肾细胞癌肾切除及免疫治疗后完全缓解患者,随访MRI发现胰尾强化病灶疑似胰腺神经内分泌肿瘤,行[18F]SiTATE SSTR-PET/CT示胰尾病灶摄取增高,行胰尾切除后病理示突触素阴性、PAX8及碳酸酐酶9阳性,最终诊断为肾细胞癌孤立性胰腺转移,其瘤内血管网络SSTR2表达可解释[18F]SiTATE摄取。
要点
- 肾细胞癌胰腺转移灶可在[18F]SiTATE SSTR-PET/CT上表现为高摄取。
- 病理示突触素阴性而PAX8及碳酸酐酶9阳性支持肾细胞癌转移诊断。
- 瘤内血管网络SSTR2表达可解释该转移灶的[18F]SiTATE摄取。
核心结论
- 最终诊断为已知肾细胞癌的孤立性胰腺转移,瘤内血管网络SSTR2表达可解释[18F]SiTATE摄取。
研究设计与样本
- 本文报告一例61岁女性肾细胞癌患者,肾切除及免疫治疗后完全缓解,随访MRI发现胰尾强化病灶疑似胰腺神经内分泌肿瘤。
- 随后在Biograph Vision Quadra上行[18F]SiTATE SSTR-PET/CT,胰尾病灶示示踪剂摄取增高,遂行胰尾切除术。
主要发现
- 随访MRI显示胰尾强化病灶,疑似胰腺神经内分泌肿瘤。
- [18F]SiTATE SSTR-PET/CT示胰腺病灶示踪剂摄取增高。
- 组织病理学示突触素无表达,PAX8及碳酸酐酶9阳性。
- 最终诊断为已知肾细胞癌的孤立性胰腺转移,伴瘤内血管网络SSTR2表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Here we present a 61-year-old woman with a history of renal cell carcinoma after nephrectomy and complete response to immunotherapy. Follow-up MRI revealed a contrast-enhanced lesion in the pancreatic tail, suspicious for a pancreatic neuroendocrine tumor. Subsequently, a SSTR-PET/CT with [ 18 F]SiTATE was conducted on a Biograph Vision Quadra. The pancreatic lesion showed intensive tracer uptake. Thus, a pancreatic tail resection was performed. Histopathologic results revealed no synaptophysin expression, but positivity for PAX8 and carboanhydrase 9. The final diagnosis was a solitary metastasis of the known renal cell carcinoma with SSTR2 expression in the intratumoral vascular network, explaining the [ 18 F]SiTATE uptake.
引用
- Mattke M, Schwaibold L, Krumm P, et al. [ 18 F]SiTATE Uptake in a Pancreatic Metastasis From a Renal Cell Carcinoma on a Long Axial Field of View PET/CT. Clin Nucl Med. 2025. PMID: 40103008. doi:10.1097/RLU.0000000000005844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。